STOCK TITAN
  1. Home
  2. News
  3. RDHL

Redhill Biopharma Ltd. - RDHL STOCK NEWS

IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma Prices $8.0 Million Underwritten Public Offering
offering
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma Announces Proposed Public Offering
offering
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma Announces Q3/22 Results and Operational Highlights
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma Announces Positive New Data with Opaganib for Nuclear Radiation Injury
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Accelerates Opaganib's Nuclear Radiation Protection Program - Positive Data Published
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma Reaches Agreement in Principle with HCR to Extinguish All Debt Obligations in Exchange for Movantik®
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma Provides H1/22 Highlights and Q3/22 Estimates
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Presents New Talicia® Data Analyses at Obesity Week 2022
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Presents New Talicia® and Movantik® Data Analyses at ACG 2022
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill's Oral Broad-Acting Antiviral, Opaganib, Granted New COVID-19 Treatment Patent
covid-19
Stock RDHL logo
Redhill Biopharma Ltd.

Nasdaq:RDHL

RDHL Rankings

#7123 Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

RDHL Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Israel
21 Haarbaa St

About RDHL

redhill biopharma is a biopharmaceutical company focused primarily on development of late clinical-stage new, improved and patented formulations of existing drugs. redhill has an experienced management team, board of directors and advisory board based in israel, the us, canada and europe, with successful track record at big and small pharma of bringing patented drugs to the market, as well as extensive managerial, financial, and transactional expertise